Invention Grant
- Patent Title: Lysosomal storage disease enzymes
-
Application No.: US17093074Application Date: 2020-11-09
-
Publication No.: US11560554B2Publication Date: 2023-01-24
- Inventor: Anthony Quinn , Alex J. Harvey
- Applicant: Alexion Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: Clark & Elbing LLP
- Main IPC: C12N9/20
- IPC: C12N9/20 ; A61K38/46 ; A01K67/027 ; A61K31/194 ; A61K38/38
Abstract:
The present invention provides compositions of recombinant human lysosomal acid lipase having particular glycosylation patterns for internalization into target cells, a vector containing the nucleic acid encoding human lysosomal acid lipase, a host cell transformed with the vector, pharmaceutical compositions comprising the recombinant human lysosomal acid lipase and method of treating conditions associated with lysosomal acid lipase deficiency.
Public/Granted literature
- US20210171922A1 LYSOSOMAL STORAGE DISEASE ENZYMES Public/Granted day:2021-06-10
Information query
IPC分类:
